ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Indo-Pacific

Why Quad boosts India's vaccine diplomacy: 5 things to know

Group to make and distribute 1bn COVID doses to counter China's moves

Indian Prime Minister Narendra Modi, right, addresses his fellow Quad Leaders, top to bottom, U.S. President Joe Biden, Japanese Prime Minister Yoshihide Suga and Australian Prime Minister Scott Morrison, from New Delhi on March 12. (Photo courtesy of Prime Minister's Office of India)

NEW DELHI -- The vaccine partnership announced by the Quad grouping comprising Australia, India, Japan and the U.S. is one of the most concrete takeaways from its leaders' first-ever summit this month, given that the world is still battling the COVID-19 pandemic more than a year after it struck.

Under the joint effort, the four nations plan to pool in their financial resources, manufacturing capabilities and logistics know-how to increase production and distribution of COVID-19 jabs to benefit the international community. India, the world's vaccine leader, which produces 60% of the world's overall vaccine needs, will make 1 billion doses of COVID-19 vaccine as part of an initiative to be financed by the U.S. and Japan, while Australia will help with "last-mile" and logistics and delivery.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more